Long-term safety and efficacy of adjunctive rasagiline in levodopa-treated Japanese patients with Parkinson’s disease

Rasagiline is a monoamine oxidase type-B inhibitor in development in Japan for Parkinson’s disease (PD). This open-label study evaluated the long-term safety and efficacy of rasagiline in Japanese patients with PD receiving levodopa. Patients were aged 30–79 years and had wearing-off or weakened eff...

Descripción completa

Detalles Bibliográficos
Autores principales: Hattori, Nobutaka, Takeda, Atsushi, Takeda, Shinichi, Nishimura, Akira, Nakaya, Ryou, Mochizuki, Hideki, Nagai, Masahiro, Takahashi, Ryosuke
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Vienna 2019
Materias:
Neurology and Preclinical Neurological Studies - Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6449487/
https://www.ncbi.nlm.nih.gov/pubmed/30635744
http://dx.doi.org/10.1007/s00702-018-1962-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6449487/
https://www.ncbi.nlm.nih.gov/pubmed/30635744
http://dx.doi.org/10.1007/s00702-018-1962-5

Ejemplares similares